Ensign Group (ENSG) Up 7.4% in 3 Months: More Growth Ahead?

04:56pm, Wednesday, 19'th Jan 2022 Zacks Investment Research
Ensign Group (ENSG) is likely to keep growing on the back of Skilled services and impressive financial strength.

Molina Healthcare (MOH) Up 14.4% in 6 Months: Growth Ahead?

03:19pm, Tuesday, 18'th Jan 2022 Zacks Investment Research
Molina Healthcare (MOH) is likely to keep growing on the back of increasing membership and higher premium revenues.
Apyx Medical Corp (APYX) CEO Charles Goodwin on Q3 2021 Results - Earnings Call Transcript
Apyx (APYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold
Apyx (APYX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold
The shares of Apyx Medical Corp (NASDAQ: APYX) increased by over 19% during intraday trading. This is why it happened.
Apyx Medical Corporation (APYX) CEO Charlie Goodwin on Q2 2021 Results - Earnings Call Transcript
Apyx (APYX) delivered earnings and revenue surprises of 14.29% and 25.27%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold
Apyx (APYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold
Apyx (APYX) delivered earnings and revenue surprises of 0.00% and 9.80%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Apyx Medical Corporation's (APYX) CEO Charlie Goodwin on Q1 2021 Results - Earnings Call Transcript
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE